ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina March 5, 2017 Most Common Mistake Scientists Make When Applying for a Job July 19, 2017 Idera, Biocryst Tie the Knot and Transform Into a Rare Disease Pharma January 21, 2018
